a hrefhttps:www.fiercepharma.compharmagilead-christens-bixlenvo-fda-nod-new-hiv-treatment-combo-pill hreflangenGilead christens Bixlenvo with FDA nod for new HIV treatment combo tableta

Some 20 years after helping introduce the first once-daily single tablet HIV regimen, Gilead Sciences has crossed the regulatory finish line with a new oral treatment option in the U.S.